Wednesday, June 10, 2026

Patent intelligence · US

US 6288095

Compounds

expired A61K 31/ 425 A IA61K 31/ 426 A IA61K 31/ 427 A IA61K/31426
Status expired
Years to expiry 0
Applicant portfolio 25
Patent details — US 6288095
Jurisdiction
US
Status
expired
Grant date
Sep 11, 2001
Expiration
Sep 6, 2021
CPC classes
A61K 31/ 425 A I, A61K 31/ 426 A I, A61K 31/ 427 A I, A61K/31426
View on Google Patents ↗

Quick answer

US 6288095 (Compounds) is held by BEECHAM GROUP PLC [US]. Status: expired. Granted Sep 11, 2001. Expires Sep 6, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
CPC classes
A61K 31/ 425 A I, A61K 31/ 426 A I, A61K 31/ 427 A I, A61K/31426, A61K/31427

More from BEECHAM GROUP PLC [US]

Related pharmaceutical patents in our USPTO index.

  1. SA 92120308

    تركيبة للاستخدام الموضعي topical composition

    BEECHAM GROUP PLC [GB] · Expires Jun 10, 2025

    expired
  2. AT E269330

    CHEMISCHE VERBINDUNGEN

    BEECHAM GROUP PLC [GB] · Expires Jul 10, 2024

    expired
  3. EP 1425277

    HARNSTOFF-DERIVATE ALS VANILLOID-REZEPTOR-ANTAGONISTEN FÜR DIE SCHMERZBEHANDLUNG

    SMITHKLINE BEECHAM PLC [GB] · Expires Jun 4, 2024

    expired
  4. SA 91110341

    مستحضر موضعي لعلاج العدوى بفيروس الحلا (القوباء) Herpesvirus

    BEECHAM GROUP PLC [GB] · Expires May 20, 2024

    expired
  5. HU P0302480

    PYRIDINONE DERIVATIVES FOR TREATMENT OF ATHEROSCLEROSIS, PROCESS FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME

    SMITHKLINE BEECHAM PLC [GB] · Expires Dec 24, 2023

    expired
  6. AT E245157

    3,9-DIAZABICYCLO-(3.3.1)-NONANYLDERIVATE, VERFAHREN UND INTERMEDIATE FÜR IHRE DARSTELLUNG UND SIE ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN

    BEECHAM GROUP PLC [GB] · Expires Aug 10, 2023

    expired
  7. HK 1004528

    Dentifrice compositions

    BEECHAM GROUP PLC [GB] · Expires Jul 5, 2023

    expired
  8. HU P0204410

    PYRIMIDINE-4-ONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE

    SMITHKLINE BEECHAM PLC [GB] · Expires May 23, 2023

    expired

Frequently asked questions

What is US patent 6288095?

US 6288095 (Compounds) is held by BEECHAM GROUP PLC [US]. Status: expired. Granted Sep 11, 2001. Expires Sep 6, 2021 (0 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 6288095?

BEECHAM GROUP PLC [US] is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 25 pharmaceutical patents for this assignee.

When does US 6288095 expire?

Our index shows an expiration date of Sep 6, 2021 (0 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.